Advertisement
Loading...

BrainsWay Ltd.

BWAY•NASDAQ
Healthcare
Medical - Devices
$15.03
$-1.29(-7.90%)
U.S. Market opens in 37h 19m

BrainsWay Ltd. (BWAY) Stock Overview

Explore BrainsWay Ltd.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

Z

Key Financials

Market Cap589.5M
P/E Ratio35.94
EPS (TTM)$0.18
ROE0.11%
Fundamental Analysis

AI Price Forecasts

1 Month$23.28
3 Months$26.73
1 Year Target$28.87

BWAY Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of BrainsWay Ltd. (BWAY) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

The current technical analysis reveals key indicators including an RSI of 41.73, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $28.87.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 35.94 and a market capitalization of 589.5M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

1-Day Change
-7.90%
5-Day Change
-12.16%
1-Month Change
-4.93%
3-Month Change
30.70%
6-Month Change
90.74%
Year-to-Date (YTD) Change
58.04%
1-Year Change
201.20%
3-Year Change
1877.63%
5-Year Change
235.49%
All-Time (Max) Change
170.81%

Contact Information

https://www.brainsway.com
972 2 582 4030
Bynet Building, Jerusalem, NaN, 9777518

Company Facts

120 Employees
IPO DateApr 17, 2019
CountryIL
Actively Trading

Frequently Asked Questions